activation

Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing

...thin a few hours of the immunological insult, upon activation by specific cytokines. CRP is, therefore, a particularly sensitive and interesting tool for monitoring inflammatory conditions and has numerous clinical applications. CRP measurement is used in the monitoring of adult and neonatal infection and immu...

Non-Invasive Diagnostic Tests for Celiac Disease

... oats. The condition is thought to result from the activation of both a T-cell and B-cell immune response, leading to mucosal inflammation, villous atrophy, and crypt hyperplasia, and is self-perpetuating with continued exposure to gluten. The classical presentation of CD, with gluten-induced abnormal intestin...

Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer

...g of ERBITUX to the EGFR blocksphosphorylation and activation of receptor-associated kinases,resulting in inhibition of cell growth, induction of apoptosis, anddecreased matrix metalloproteinase and vascular endothelial growthfactor production. In vitro, ERBITUX can mediate antibody-dependentcellular cytotoxici...

Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression

...cer cells by facilitatingapoptosis. In this study, activation of p53 in-vivo in mice as wellas in cultured human cells induced the expression of a specificmicroRNA (miR-34a). Based on the likelihood that miR-34a coulditself play a role in cellular apoptosis, researchers introducedmiR-34a directly into human can...

Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis

...une reaction. Immunotherapeutic:a product aimed at activation of the immune system to modify andinterfere with a certain disease process. Monotherapy: treatment with one drug as opposed to combinationtherapy. Here the term refers to treatment with CYT003-QbG10 alonein contrast to a regimen where CYT003-QbG10 is...

Researchers Discover Method for Identifying How Cancer Evades the Immune System

...suppression of CD83 and CD28,two genes that affect activation of immune cells, andover-production of B7-H4, a gene whose protein product inhibitsimmune activation. The human colorectal cancers, however, showedvariations in their immune signatures, which researchers saw as anindication of the need to understand ...

ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop

...ect on mitochondrial functions andconsequently the activation of the signal transduction pathwayleading to apoptosis. In addition, darinaparsin interrupts the cellcycle at the G2/M phase of tumor cells inducing cell death throughthis pathway. About ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc. is a biopharm...

Expert Opinion Highlights Avigen's AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal

...perties, AV411 attenuates or suppresses glial cell activation inbrain and spinal cord tissues and is effective in treating painsymptoms. Additionally, the article reports that AV411 potentiatesor augments morphine analgesia, while counteracting morphinetolerance, as well as diminishing morphine withdrawalbehavi...

Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease

...gs to treatdiseases of aging, announced today that activation of SIRT1, amember of the sirtuin family of enzymes...on, without requiring a change ineating habits, by activation of sirtuins, a recently discoveredclass of enzymes that control the aging process. The company'shead...

Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event

...causes platelets to bind when dephosphorylatedupon activation of EP3, was found to provide such a biomarker. Thecompany thus began a clinical pharmacology study to examine DG041'seffectiveness in blocking VASP-mediated platelet activation. The results of these studies presented today provide acompelling demons...

New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines

...pethat can be cultured, as well as measure caspase activation insidemultiple cell types (e.g., cancer cells, immune cells, or celllines from different organ systems or genetically engineeredcells). This allows researchers to find potential drug candidatesthat are selective for specific cancer types, which may h...

Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy

...of a co-stimulatory signalrequired for full T-cell activation and works in a fundamentallydifferent way than cytokine antagonists, including TNFantagonists. Bristol-Myers Squibb Company is a global pharmaceutical andrelated health care products company whose mission is to extend andenhance human life. CONTACT...

Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action

... and differentiation of cells; however theaberrant activation of this pathway results in uncontrolled tumorgrowth. Dr. Brent Stockwell, currently an Associate Professor ofBiological Sciences and of Chemistry at , identified erastin as asmall molecule anti-cancer agent that exhibits lethality in humantumor ce...

Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Society's Annual Meeting

...hile avoidingside effects commonly associated with activation of thyroid hormonereceptors outside the liver. If we can demonstrate thesecharacteristics in humans, it should provide important evidencethat MB07811 and this class of drugs could represent an excitingnew therapeutic approach for treating hyperlipide...

Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting

...g of ERBITUX to the EGFR blocksphosphorylation and activation of receptor-associated kinases,resulting in inhibition of cell growth, induction of apoptosis, anddecreased matrix metalloproteinase and vascular endothelial growthfactor production. In vitro, ERBITUX can mediate antibody-dependentcellular cytotoxici...

Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients

...ts and binds to the EGFR. This binding inhibitsthe activation of the receptor and the subsequentsignal-transduction pathway, which results in reducing both theinvasion of normal tissues by tumor cells and the spread of tumorsto new sites. It is also believed to inhibit the ability of tumorcells to repair the da...

Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in Phase 2 Trial

...ast and uterinecancers is associated with ER alpha activation and that ER betablocks the growth promoting effects on breast cancer cells. Bionovorecognized the opportunity to commercialize a product that would beequally effective, with an improved safety profile compared totraditional hormone therapy. The clini...

Innovive Pharmaceuticals to Present Interim Data from Phase I Study of INNO-406 at the American Society of Clinical Oncology Annual Meeting

...recognized cause ofimatinib resistance. Lyn kinase activation has also been documentedin a variety of solid tumors, including prostate cancer. About INNOVIVE Pharmaceuticals INNOVIVE Pharmaceuticals, Inc. acquires, develops andcommercializes novel therapeutics addressing significant unmetmedical needs in the ...

MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations

...e pro-inflammatory protein HMGB1, implicatedin the activation of B cells, may contribute to the pathology of ara...9 dependent DNA Immune complex mediated cell activation by High Mobility Group Box Protein 1 (HMGB1) and Receptor for Advanced Glycation End products ...

Positive results from placebo-controlled phase IIa study in patients suffering from house dust mite allergy

... dust mites. Immunotherapeutic: a product aimed at activation of the immunesystem to modify and interfere with a certain diseaseprocess. Median: a term used in the statistical analysis of a set ofnumbers; relates to or constitutes the middle value in adistribution. 50% of the values are above and 50% below the ...

Gemin X Biotechnologies Announces Publication in Blood of Positive Preclinical Data of Lead Compound in Mantle Cell Lymphoma

... inMantle Cell Lymphoma by enhancing Noxa-mediated activation of Bak."It was led by Patricia Perez-Galan et al.,...reclinical activity of GX15-070 led toan increased activation of the apoptotic pathway, while showing nosignificant cytotoxic effect in normal cells from healthy ...

Independent publication supports the profile of CeNeS phase II compound, CNS 5161

...ties that make it possible tomonitor NMDA receptor activation in the human brain. The profile ofCNS 5161 as a selective, high affinity and brain-penetrating agentnow make this a possibility. These properties of CNS 5161, togetherwith its low liability to induce side-effects, are the scientificfoundation for our...

Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer

...gen and nitrogen species. Inhibition isachieved by activation of the antioxidant transcription factorNrf2, which...s. In addition, thetriterpenoids directly regulate activation of NF-kB by binding toIKKB, the kinase that inhibits NF-kB activation. The triterpenoidsblock the ac...

Telomerase Presentations at the AACR 2007 Annual Meeting

... on thedegree of telomere loss prior to telomerase activation in varioustumor types, the role of telomere dysfunction in tumorigenesis, anduse of the telomerase promoter to drive tumor cell death. "The data presented at AACR contribute to the growing body ofevidence regarding the importance of telomerase targe...

Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR

...pethat can be cultured, as well as measure caspase activation insidemultiple cell types (e.g., cancer cells, immune cells, or celllines from different organ systems or genetically engineeredcells). This allows researchers to find potential drug candidatesthat are selective for specific cancer types, which may h...

VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting

...n Phase I/IIa clinictrials: VQD-002 which inhibits activation of Akt that is seen atabnormally high levels in breast, ovarian, colorectal, pancreatic,and hematologic tumors; and Lenocta (TM), an inhibitor of specificprotein tyrosine phosphatases, which has shown compellingpreclinical activity in both renal and ...

MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases

...ey component ofDNA-immune complexes that stimulate activation of B cells andplasmacytoid dendritic cells (pDCs) via the toll-like receptor 9pathway (TLR9). Both B cells and pDCs are associated with immunesystem disorders such as lupus. The data also suggest that HMGB1DNA-immune complexes augment production of i...

Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR

...mbrane alterations (Annexin V binding) and caspase activation in cancer cells. NEI treatment induces cell cycle arrest, but not apoptosis, in normal cells. NEIs show potent activity as single agents in in vivo tumor models and may also have application in combination therapies as NEIs ar...

Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Bruton's Tyrosine Kinase Inhibitors

...tion. Drugsthat can inhibit BTK may prevent B-cell activation and thereforemay play a role in treatment of lymphomas or autoimmune disease.Other tyrosine kinases are important in cell signaling and havebeen targets for other drugs such as imatanib mesylate(Gleevec(R)), which is approved for treatment of certain...

Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) on Clinical Product Candidate, CT-322

...e tyrosine kinasereceptor, VEGFR-2, and blocks its activation by all knownextracellular ligands; VEGF-A, VEGF-C,...ng of the VEGFR-2 pathway in tumorsettings and its activation by VEGF-A, C and D. We are veryencouraged by the emerging CT-322 Phase 1 data, and we look forwardto...

Curis Announces Hedgehog and Wnt Antagonist Data Presentation at AACR

...icularly forpotential cancer indications. Abnormal activation of Wnt signalingis present in various cancers, including colon, breast and ovariancancers. Developing drug candidates that are designed to inhibit,or antagonize, Wnt signaling could hopefully provide a potentialoption in certain cancers. On April 14...

Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients

...g of ERBITUX to the EGFR blocksphosphorylation and activation of receptor-associated kinases,resulting in inhibition of cell growth, induction of apoptosis, anddecreased matrix metalloproteinase and vascular endothelial growthfactor production. In vitro, ERBITUX can mediate antibody-dependentcellular cytotoxici...

Biomira Selects PX-866 as Clinical Development Candidate and Presents Promising Preclinical Data at AACR

...sitivity to PX-866.Treatment with PX-866 inhibited activation of AKT and otherdownstream targets of PI3K. A dose-dependent increase in autophagy,a type of programmed cell death, was observed and PX-866 alsoinhibited invasive and angiogenic capabilities of cultured gliomacells. In animals, PX-866 inhibited subcu...

Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models

...tern. Number 2128: Blockade of tumor-derived VEGF activation of VEGFreceptor 2 reduces macrophage infiltration into tumors anddecreases metastasis in a pre-clinical orthotopic model ofpancreatic cancer, Juliet G. Carbon, Shane E. Holloway, Andrew F.Miller, Anita Kavlie, Kyle Schlunegger, Jason B. Fleming, Rolf...

Vion Presents Data on Cloretazine (VNP40101M) at the 100th Annual Meeting of the American Association of Cancer Research (AACR)

...e(R) binds with iron andcauses S- phase arrest and activation of the apoptotic pathway inadvanced cancer patients" will be presented on Monday, April 16from 8 a.m. to 12 p.m. Vion Pharmaceuticals, Inc. is committed to extending the livesand improving the quality of life of cancer patients worldwide bydevelopin...

Innovive Pharmaceuticals Announces Additional Data Presentations at American Association for Cancer Research Annual Meeting

...recognized cause of imatinibresistance. Lyn kinase activation has also been documented in avariety of solid tumors, including prostate cancer. About INNOVIVE Pharmaceuticals INNOVIVE Pharmaceuticals, Inc. acquires, develops andcommercializes novel therapeutics addressing significant unmetmedical needs in the ...

Innovive Pharmaceuticals Announces Data from Oncology Drug Programs to be Presented at American Association for Cancer Research Annual Meeting

...recognized cause of imatinibresistance. Lyn kinase activation has also been documented in avariety of solid tumors, including prostate cancer. About INNO-206 INNO-206 (formerly DOXO-EMCH) is a doxorubicin prodrug designedto preferentially reach the tumor and reduce adverse eventscompared to native doxorubicin...

Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma

... a novel,oral syk kinase inhibitor that blocks the activation of mast cells,macrophages and B-cells that promote...armacodynamic endpoints, as well as the roleof syk activation in predicting responses, will also be measured.Depending on enrollment, results of the clinical tria...

Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer

...g of ERBITUX to the EGFR blocksphosphorylation and activation of receptor-associated kinases,resulting in inhibition of cell growth, induction of apoptosis, anddecreased matrix metalloproteinase and vascular endothelial growthfactor production. In vitro, ERBITUX can mediate antibody-dependentcellular cytotoxici...

Inotek Pharmaceuticals Announces Publication of Animal Data from Study of PARP Inhibition as Potential Preventative of Brain Injury Following Stroke

...zyme that directs therepair of damaged DNA via the activation and recruitment of DNArepair enzymes and has poten...eonset of reperfusion. Researchers measured the activation of brain macrophages, knownas microglial cells, at several time-points between 0 and 14 daysfollowin...

Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

...g of ERBITUX to the EGFR blocksphosphorylation and activation of receptor-associated kinases,resulting in inhibition of cell growth, induction of apoptosis, anddecreased matrix metalloproteinase and vascular endothelial growthfactor production. In vitro, ERBITUX can mediate antibody-dependentcellular cytotoxici...

Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

...g of ERBITUX to the EGFR blocksphosphorylation and activation of receptor-associated kinases,resulting in inhibition of cell growth, induction of apoptosis, anddecreased matrix metalloproteinase and vascular endothelial growthfactor production. In vitro, ERBITUX can mediate antibody-dependentcellular cytotoxici...

CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies

...normal cellular protein repair pathway through the activation of"molecular chaperones." Since damaged proteins called aggregatesare thought to play a role in many diseases, CytRx believes thatactivation of molecular chaperones could have therapeutic efficacyfor a broad range of diseases. About CytRx Corporatio...

Immunosuppressant Drug Prevents Tobacco Induced Lung Cancer in Mice

...rmal cells that line the airways inthe lungs. This activation makes the cells pre-cancerous. Inaddition, clinical studies have shown that Akt is activated in themajority of pre-cancerous lesions in smokers, and that Aktactivation predicts shorter survival for non-small cell lung cancerpatients, particularly for...

Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical Data for INO-1001 at ACC Demonstrating PARP Inhibition and Anti-inflammatory Activity in Plasma of Patients Undergoing Primary Percutaneous Coronary Intervention

... the repair of DNA single strand breaks throughthe activation and recruitment of DNA repair enzymes. PARP's rolein the inflammatory response may result from its ability topotentiate the activity of key inflammatory transcription factors(NF-kappaB and AP-1). PARP inhibitors have shown promise in avariety of infl...

Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity

...lf" and foreignmolecules by T cells occurs through activation of a cell surfacereceptor called the T cell receptor. Activation of T cells throughthe T cell receptor involves the complex regulation of multiplebiological pathways inside the cell. miRNAs are a broad class ofsmall RNAs that have been shown to regul...

Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's Onconase

...ted by classical changes incell morphology and the activation of caspase-3, both consideredhallmarks of the apoptotic mode of cell death. "This is very encouraging data that support our work ininvestigating multiple therapeutic options for the ONCONASEfranchise," said Kuslima Shogen, Alfacell's chairman and ch...

ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent

...y reported by Homspera is similarly consistentwith activation of components of innateimmunity that have beenreported to have anti-anthrax activity, such as defensins. "Whilethese results from the use of Homspera are preliminary, we believethat upcoming studies in non-human primates may provideconfirmation that ...

Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases

...rect injection into thetarget tissue and selective activation by PSA produced only by thetarget tissue. The paper, entitled "A prostate-specificantigen-activated channel-forming toxin as therapy for prostaticdisease" (JNCI, Vol.99, Issue 5 pp, 376-385) found that: PRX302 direct injection into the prostate did n...

Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal

...ce it isknown that proper evaluation of complement activation is bestperformed in this type of animal prior to human use. "The experimental work reported in this paper shows thatCALAA-01 can safely be repeatedly administered to large animals,"said Jeremy Heidel, Calando's Chief Scientific Officer. "Weobserved ...

ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met Inhibitor, for Oral Presentation at ASCO

...c-Met inhibition and DNA damageresponse/checkpoint activation platforms. They represent a broadscope of findings...l death in cancer cells by(beta)-lapachone through activation of DNA damage responsepathway -- Evaluation of biomarkers for HGFR/c-Met inhibitor ARQ 197 ina huma...

Study of Drug Therapy for Compulsive Buying Yields a Puzzle, Stanford Researcher Says

...ses. "We would look for a difference in the brain activation patternsof those who respond to the drug vs. those who don't," saidKoran. The inconclusive nature of the results from the latest trial ofescitalopram should not discourage anyone suffering from compulsivebuying from seeking treatment, since several ...

Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients

...munotherapy / immunotherapeutic: a therapy aimedat activation of the immune system to modulate a certain diseaseprocess. Conventional immunotherapy for allergic diseases,also termed desensitization, is performed with allergen.CYT003-QbG10 appears to act differently, namely through anallergen-independent mechan...

Scottish Scientists Test ‘Secret Weapon’ Against Tumours

...udy has shown for the firsttime that the selective activation of a gene called p73 can causecell death in tumours. We think this approach has the potential tobe developed into an effective treatment for cancer.” The gene p73 is related to p53 – one of the most importantgenes known to protect agains...